Catch up on some of the most exciting advancements in clinical microbiology and infectious disease presented at ECCMID 2022
Peak Proteins' expertise in protein crystallography will enhance Sygnature Discovery’s fragment screening and analysis activities as well as its structure-based drug design capabilities
The three companies will work to accelerate development of automated insulin delivery system for people living with diabetes
The Sero Krystal™ PDL range of coated microplates from Porvair Sciences set a new benchmark for reproducible cell culture even with challenging cell types
Discover the latest analytical weighing solutions helping users remain compliant for the development and testing of cosmetics and personal care products
Watch the series of on-demand webinars to hear from the experts on internal quality control practices and applications
Watch this on-demand webinar to discover the role played by TGF-ß in the chronic immune reaction in severe cases of COVID-19
First product within new ‘in-a-box’ range, which harnesses next-generation, human-relevant Liver-on-a-Chip technology to improve the accuracy and efficiency of NASH drug discovery
Discover how Biorbyt used ethical techniques to produce a new line of research tools to meet the challenges of the pandemic
Antibodies against COVID-19 were found in the blood of 85% of newborn babies whose mothers tested positive for IgG antibodies against COVID-19 while pregnant
Findings suggest women with COVID-19 during pregnancy are five times more likely to be hospitalized, and six times as likely to require treatment in intensive care
Study in over 20,000 Canadian adults hospitalized with COVID-19 finds vaccination with at least one dose is linked with a significantly lower risk of ICU admission and death
Analysis of antimicrobial resistance in 271 US hospitals finds higher rates of antibiotic-resistant infections in both COVID-19 patients and SARS-COV-2 negative patients admitted during the pandemic compared to pre-pandemic
The report provides real-world treatment and outcome data for 850,000 US adults hospitalized with COVID-19 over 20 months of the pandemic
Trial results presented at ECCMID show potential of Actiphage for risk stratification in those with latent TB
Three-day in-person educational event allows attendees to network and learn in over 100 sessions focused on cannabis analytical science, medicine/wellness, cultivation, hemp and psychedelics
Blood test could be used to identify patients most likely to become severely ill before they deteriorate
The researchers were able to build a decision tree to predict COVID-19 patients at risk of a poor prognosis
Leafy greens are particularly susceptible to contamination due to their proximity to the ground and the likelihood of people eating them without cooking
Nursery children were found to be exposed to the greatest variety of pathogens and the highest concentrations compared to other groups investigated
An electronic questionnaire was used to gather information about sick leave and side effects from the 1,797 healthcare workers
Blood-based assay has the potential to serve the multiple sclerosis (MS) community in management of relapsing-remitting form of the disease
